Company intelligence / Profile preview

Pebble Labs

Los Alamos, New Mexico, United Statespebblelabs.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Pebble Labs has developed a proprietary platform called Directed Biotics™, which uses precision-engineered microbes to deliver targeted RNA-based solutions for protecting crops and aquaculture from diseases and pests. The company aims to provide sustainable alternatives to chemical pesticides and antibiotics. No clinical results are available as the focus is on agricultural applications rather than human therapeutics.

Therapeutic areas: OtherInfectious Diseases
Modalities: RNA therapyMicrobial therapy
Industry: Agriculture & AgTech

Partnerships

Participated in Unreasonable Impact Americas program with Barclays support

Beyond the preview

Go deeper on Pebble Labs.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pebble Labs.

Explore the full profile